CD Biosynsis offers specialized services for the precise engineering and validation of Reporter Cell Lines. These lines are critical tools for high-throughput screening, drug discovery, and fundamental research, providing a quantifiable readout of specific biological events (e.g., pathway activation, receptor binding, or gene expression). We utilize advanced gene editing techniques, including CRISPR/Cas9, to integrate a reporter gene (such as Luciferase, GFP, or Beta-Lactamase) under the control of a specific promoter or regulatory element.
Our expertise ensures the final cell line exhibits high sensitivity, low background noise, excellent stability, and a robust signal-to-noise ratio, enabling reliable and reproducible assays. We develop custom reporter lines for various applications, including signaling pathway analysis, compound toxicity testing, and specific gene target validation in any major mammalian host cell (e.g., CHO, HEK293, HepG2).
Get a QuoteReporter cell lines serve as functional biosensors, converting an intracellular biological event into an easily measurable signal. This ability to capture real-time, dynamic information makes them indispensable for screening large compound libraries and understanding the kinetics of cellular responses. Our development process prioritizes genomic stability; the reporter cassette is stably integrated into a defined, neutral locus to prevent position effects and ensure the signal remains consistent over many passages.
We work with both transcriptional reporters (where the reporter gene is driven by a pathway-responsive promoter) and translational reporters (where the reporter is fused to a protein of interest). The choice of reporter (Fluorescent, Luminescent, or Enzymatic) is optimized based on the required throughput, sensitivity, and the nature of the biological signal being measured.
Check the box next to the pathway of interest:
NF-kB Pathway Reporter
Wnt Signaling Pathway Reporter
GPCR Activation Assay Line
MAPK/ERK Pathway Reporter
ARE/NRF2 Stress Response
Hypoxia (HIF-1alpha) Reporter
Nuclear Receptor Reporter
JAK/STAT Pathway Reporter
Select the preferred readout for your screening campaign:
Firefly Luciferase (High Sensitivity)
Renilla Luciferase (Normalization)
GFP/mCherry (Flow Cytometry)
Beta-Lactamase (FRET Assay)
Cytotoxicity Reporter
Apoptosis/Cell Death Reporter
Dual Reporter Systems
Non-Toxicity Readout
Endogenous Promoter Tagging
CRISPR-mediated insertion of the reporter gene immediately downstream of a native, pathway-responsive promoter to monitor its activity.
Translational Fusion
Tagging the endogenous protein of interest with a fluorescent reporter to track its localization, stability, or post-translational modifications.
miRNA Sensor Lines
Developing lines where reporter expression is repressed by a specific microRNA, allowing for functional validation of RNA regulatory networks.
A systematic process for generating highly sensitive and stable reporter cell lines.
Design & Vector Construction
Engineering & Selection
Characterization & Validation
Expansion & Delivery
System Design: Select the appropriate promoter element (native or synthetic) and the reporter gene (Luminescence or Fluorescence).
Vector Construction: Generate the high-quality gene targeting vector, often including homologous arms for targeted genomic integration.
Gene Editing: Perform CRISPR/Cas9-mediated gene targeting and introduce the reporter cassette into the host cells.
Single-Cell Cloning: Isolate and expand individual cell clones to ensure homozygosity and monoclonality for stable performance.
Functional Assay: Validate the reporter line by applying the pathway agonist and antagonist to measure the dynamic range and fold induction.
Stability Testing: Culture clones over multiple passages (>30) to confirm the reporter signal and genomic integration remain consistent and stable.
High Signal-to-Noise Ratio
Systems are optimized for low background signal and strong induction, enabling clear differentiation between hits and non-hits.
Guaranteed Genomic Stability
Reporters are stably integrated into a neutral chromatin environment via gene editing, ensuring reliable long-term assay performance.
Applicable to HTS
Designed for automated liquid handling and multi-well plate reading, compatible with 96, 384, and 1536-well plate formats.
Customizable Hosts
Expertise in engineering reporter lines in diverse hosts, including HEK293, CHO, primary cells, and stem cells, tailored to your needs.
"The NF-kB Luciferase Reporter Line delivered by CD Biosynsis showed a 50-fold induction with agonist treatment and negligible background, which is far superior to commercial kits. It accelerated our HTS campaign significantly."
Dr. Sarah Johnson, Lead Assay Development Scientist
"We required a stably integrated GPCR reporter in CHO cells. Their CRISPR-based integration was flawless, and the line has maintained its high dynamic range for over six months in culture."
Ms. Elena Rodriguez, Senior Research Associate
"The custom HepG2 toxicity reporter line allowed us to reliably screen our compound library for liver toxicity early on, saving considerable time and resources in later preclinical stages."
Mr. Kenji Tanaka, Director of Preclinical Development
"We commissioned CD Biosynsis to support an intricate gene editing project with multiple targets. Their talent in producing high-quality work in a short period of time was impressive. Their solutions were custom made to suit our needs, and they went above and beyond to ensure our experiments worked. Their support has been a great asset to our research department and we look forward to further working with them."
Dr. Raj Patel, Principal Investigator, University Research Center
"As a pharmaceutical company working to discover new therapies, we require accurate, trustworthy gene editing solutions. CD Biosynsis did more than what we expected when it came to providing strong, accurate CRISPR/Cas9 solutions for our preclinical research. Their technical support team was excellent and responsive, and they quickly replied to our questions. This alliance has been pivotal in helping us move our drug pipeline forward. Thank you, CD Biosynsis, for your amazing service!"
Dr. David Lee, Chief Scientist, Biotech Firm
What is the most critical factor for a reporter cell line's success?
The most critical factor is the signal-to-noise ratio and genomic stability. A high signal-to-noise ratio ensures clear assay results, minimizing false positives/negatives. Genomic stability, achieved through targeted integration (CRISPR), guarantees that the cell line performs consistently over long periods and passages.
How do you ensure the reporter line is monoclonal?
After successful gene editing and selection, we perform stringent single-cell cloning using FACS (Fluorescence-Activated Cell Sorting) or limiting dilution to ensure that all cells in the final batch originate from a single, verified parental cell.
Which reporter gene should I choose (Luciferase vs. GFP)?
Luciferase (Luminescence) offers extremely high sensitivity and is ideal for endpoint assays and high-throughput plate reading. GFP (Fluorescence) is better for real-time, live-cell monitoring, tracking protein localization, and analysis using flow cytometry or microscopy. The choice depends entirely on your assay format.
What is a Dual Reporter System?
A dual reporter system uses two different reporters simultaneously. One reporter is typically used as the experimental readout (e.g., Firefly Luciferase controlled by the pathway), and the second (e.g., Renilla Luciferase driven by a constitutive promoter) is used as an internal control to normalize for cell number or assay variability.
How much does Metabolic Engineering services cost?
The cost of Metabolic Engineering services depends on the project scope, complexity of the target compound, the host organism chosen, and the required yield optimization. We provide customized quotes after a detailed discussion of your specific research objectives.
Do your engineered strains meet regulatory standards?
We adhere to high quality control standards in all strain construction and optimization processes. While we do not handle final regulatory approval, our detailed documentation and compliance with best laboratory practices ensure your engineered strains are prepared for necessary regulatory filings (e.g., GRAS, FDA).
What to look for when selecting the best gene editing service?
We provide various gene editing services such as CRISPR-sgRNA library generation, stable transformation cell line generation, gene knockout cell line generation, and gene point mutation cell line generation. Users are free to select the type of service that suits their research.
Does gene editing allow customisability?
Yes, we offer very customised gene editing solutions such as AAV vector capsid directed evolution, mRNA vector gene delivery, library creation, promoter evolution and screening, etc.
What is the process for keeping data private and confidential?
We adhere to the data privacy policy completely, and all customer data and experimental data are kept confidential.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.